• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Allergan promotes a company VP to president | Personnel Moves

Allergan promotes a company VP to president | Personnel Moves

June 26, 2013 By Sony Salzman

fired/hired

The board of Allergan (NYSE:AGN) named Douglas Ingram president following 17 years in other upper management roles at the Irvine, Calif., drug and device maker. Ingram was most recently president and executive VP of the company’s European, African and Middle East regions.

Ingram has worked a wide range of jobs at Allergan, including leading roles in compliance, internal audit controls, human resources, regulator affairs and public relations.

Ingram was a lawyer before joining Allergan in 1996, according to a company statement.

 New VP of R&D will join AtriCure from Medtronic
Medtronic’s (NYSE:MDT) director of R&D for the structural heart business is slated to join AtriCure (NSDQ:ATRC) later this summer as VP of R&D. At Medtronic, he worked on radiofrequency and cryogenic surgical ablation technologies and designed the medtech giant’s Cardioblate irrigated ablation system. He holds 50 patents, and Twin Cities Business named him a top inventor in 2013.  
Read more

 New global marketing and BD executive at Exalenz
As Exalenz Bioscience ramps up for market launch of its BreathID device, the company appointed Ted Foltyn as its new VP of worldwide marketing and business development. CEO Lawrence Cohen, who only stepped into the corner office this March, said Foltyn’s appointment is part an expanding marketing and BD team. Foltyn is a former senior director of sales and marketing at Johnson & Johnson (NYSE:JNJ).
Read more

 Patient data company PHT Corp. names COO
PHT Corp., which develops systems to collect patient-driven electronic data, brought on a new operations chief. Steven Rosenberg previously worked as VP of software at Oracle Corp.’s health science and global business unit. He has more than 30 years of experience in Boston-area high-tech companies, according to PHT.
 
Read more

 Titan Spine pulls a new VP in from within company ranks
Mark Berg, who joined Titan Spine in 2010, was named the company’s new senior VP of global operations. He has worked for a number of medical device heavyweights, including DePuy, Medtronic Sofamor Danek and Biomet 3i.
Read more

Filed Under: News Well Tagged With: Allergan, AtriCure Inc., Exalenz Bioscience, Personnel Moves, Titan Spine

More recent news

  • Alpheus Medical raises $52M for ultrasound-activated tumor therapy
  • Elucent Medical wins FDA breakthrough nod for in-body spatial intelligence system
  • EndoQuest Robotics completes first cases in pivotal surgical robot trial
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications
  • Intuitive Surgical is making a CEO change

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy